pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

pandion-therapeutics PRESS RELEASE ARCHIVE

Apr 1, 2021

Merck Completes Acquisition of Pandion Therapeutics

Mar 16, 2021

Selexis Enters Service Agreement with Pandion Therapeutics to Advance Pandion Antibody

Mar 4, 2021

Merck Begins Tender Offer to Acquire Pandion Therapeutics

Mar 1, 2021

PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick and Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND

Feb 27, 2021

SHAREHOLDER ALERT: Monteverde and Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND

Feb 25, 2021

Merck to Acquire Pandion Therapeutics

Feb 25, 2021

Pandion Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Pandion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PAND

Feb 25, 2021

Merck to Acquire Pandion Therapeutics

Feb 22, 2021

Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting

Nov 23, 2020

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics using novel discovery platforms

Jun 9, 2020

Pandion Therapeutics Announces Issuance of U.S. Patent for Bifunctional Molecules Derived from TALON™ Platform

May 19, 2020

Pandion Therapeutics Appoints John S. Sundy, M.D., Ph.D., as Chief Medical Officer

Apr 1, 2020

Pandion Therapeutics Announces Close of $80 Million Series B Financing

Feb 25, 2020

Pandion Therapeutics to Present at Cowen and Co. 40th Annual Health Care Conference

Feb 18, 2020

Pandion Therapeutics to Present at SVB Leerink 9th Annual Global Healthcare Conference

Jan 28, 2020

Pandion Therapeutics Announces Appointment of Don Frail, PhD, to Its Board of Directors

Jan 13, 2020

Ligand Enters into OmniAb Platform License Agreement with Pandion Therapeutics

Dec 11, 2019

Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration

Jul 17, 2019

Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer

Apr 11, 2019

Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics

Oct 2, 2018

FierceBiotech Names Pandion Therapeutics as One of Its “Fierce 15” Biotech Companies of 2018

Sep 18, 2018

Just Biotherapeutics Announces Product Development and Manufacturing Agreement with Pandion Therapeutics

Jul 26, 2018

Pandion Therapeutics Announces Appointment of Nancy Stagliano to Its Board of Directors

Apr 16, 2018

Applied BioMath, LLC Announces Collaboration with Pandion Therapeutics for Semi-Mechanistic Pharmacokinetic and Target Occupancy Modeling in Autoimmune Disease

Jan 18, 2018

Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases

Dec 12, 2017

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

Google Analytics Alternative